Sanat Chattopadhyay, MSD executive vice-president and president of its manufacturing division, said the expansion was “another new chapter in our long-standing legacy in Ireland”
Carlow was MSD’s first vaccines site outside the US when it was opened in 2008. It now operates as a filling site for both new and existing MSD vaccines, biologics medicines and older generation small molecule drugs. Specialising in providing drug substance for clinical trials and early phase development, it is understood to be the US drug giant’s first such plant outside the US. The latest investment was focused on developing a new research facility next to the biologics manufacturing plant in a move the company says will significantly accelerate the time it takes to bring a medicine to market.
ประเทศไทย ข่าวล่าสุด, ประเทศไทย หัวข้อข่าว
Similar News:คุณยังสามารถอ่านข่าวที่คล้ายกันนี้ซึ่งเรารวบรวมจากแหล่งข่าวอื่น ๆ ได้
แหล่ง: IrishTimes - 🏆 3. / 98 อ่านเพิ่มเติม »